𝔖 Bobbio Scriptorium

✦ LIBER ✦

603 Prospective evaluation of the prognostic value of p53, K-ras, Ki67 in radically resected non-small cell lung cancers randomized in a clinical trial of adjuvant chemotherapy (ALPI trial)

✍ Scribed by Scagliotti, G.V.; Ferrari, G.; Leonardo, E.; Marchetti, A.; Torri, V.; Flann, M.

Book ID: 123196217
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 152 KB
Volume: 18
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(97)89983-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of prognostic significance of p53 a

Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small cell lung cancer: Results from an ECOG prospective randomized trial of postoperative adjuvant therapy (E3590, INT0015)

✍ Schiller, J.H; Adak, S; Feins, R; Keller, S.M; Fry, W.A; Livingston, R.B; Hammon 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 120 KB

53 POSTER A phase II, multicenter, rando

53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastin®) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarceva®) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer

✍ R. Herbst; V. O'Neill; L. Fehrenbacher; C. Belani; P. Bonomi; L. Hart; O. Melnyk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB